Versuchen GOLD - Frei
A simplistic bull case
Business Standard
|March 09, 2026
Abeguiling theory is doing the rounds in India’s financial circles — that the country’s stock market has become unusually attractive for foreign investors; if only the billion-dollar global funds with the best of talent wised up, they can grow their investment eight times in dollar terms over the next two decades.
According to this theory, India will enter a prolonged period of high growth, low inflation, and minimal currency depreciation, thanks to continued structural reforms, improved labour productivity, higher female labour-force participation, transition from an informal to a formal economy, and deeper credit penetration. Foreign investors would miss this “golden age” prosperity at their own peril.
This proposition rests on two heroic assumptions. First: India can sustain an 8 per cent annual growth rate for decades. Second: Inflation will remain subdued enough to prevent meaningful depreciation of the rupee.
That easy 8% growth
In theory almost any economy can grow at 8 percent for a few years. Doing so for decades is far rarer. It requires policy continuity, relentless implementation, and an ability to correct course when things go wrong. India faces several structural frictions. The most immediate is the weakness of private capital expenditure. During the boom preceding the 2008 global financial crisis, the country’s investment rate rose to almost 38 per cent of gross domestic product (GDP), supporting several years of rapid expansion. Since then it has slipped back to the low 30s. Public spending on infrastructure has risen sharply, but government investment alone cannot replicate the dynamism of a broad private-investment cycle. Many firms remain cautious, wary of uneven demand and an uncertain global environment.
Diese Geschichte stammt aus der March 09, 2026-Ausgabe von Business Standard.
Abonnieren Sie Magzter GOLD, um auf Tausende kuratierter Premium-Geschichten und über 9.000 Zeitschriften und Zeitungen zuzugreifen.
Sie sind bereits Abonnent? Anmelden
WEITERE GESCHICHTEN VON Business Standard
Business Standard
Nalco urges Odisha govt to expedite land handover process for ‘30K cr projects
Navratna central public-sector enterprise (CPSE) Nalco has requested the Odisha government to expedite the land handover process for its 30,000 crore expansion projects that will boost capacity and help it achieve the Maharatna status by 2030.
1 mins
March 10, 2026
Business Standard
Women-led startups saw 9% funding drop in 2025
Female labour participation just 42%, among lowest in G20: Axis Bank study
3 mins
March 10, 2026
Business Standard
How India can kick the West Asian oil habit
Increasing the use of alternative fuels like ethanol could be one way out
6 mins
March 10, 2026
Business Standard
India’s T20 WC win brings new stars to brand crease
\"Sachin Tendulkar carried Indian cricket on his shoulders for 21 years.
3 mins
March 10, 2026
Business Standard
UBS downgrades OMCs as oil crosses $100/bbl
The recent rally in crude prices and refining margins create a sense of déjà vu, UBS said, mirroring the 2022 oil market disruption.
1 min
March 10, 2026
Business Standard
LIC drove 18% rise in life insurers’ NBP in Feb
New business premium of life insurance companies grew 18 per cent year-on-year (Y-o-Y) to ₹35,417 crore in February, driven by robust growth at the state-owned Life Insurance Corporation of India (LIC) due to a favourable base.
1 mins
March 10, 2026
Business Standard
Why India needs Russian oil
India's oil security is becoming increasingly fragile. Over 80 per cent of its crude imports come from just two suppliers — West Asia and Russia — both now facing geopolitical stress. In this environment, resuming full purchases of Russian oil may not be a choice but a necessity. Here are eight reasons why.
3 mins
March 10, 2026
Business Standard
India, Uzbekistan launch pharma-nutra corridor
India and Uzbekistan on Monday launched a structured pharmaceutical and nutraceutical trade corridor aimed at expanding access to the Commonwealth of Independent States (CIS) and the wider Eurasian healthcare market, estimated at $7-10 billion.
1 min
March 10, 2026
Business Standard
A clear derating
Markets risk underperformance if we don’t regain our growth credentials
5 mins
March 10, 2026
Business Standard
Delhi HC allows Dr Reddy’s to make semaglutide for export
A division Bench of the Delhi High Court on Monday affirmed a single-judge Bench’s order allowing pharmaceutical company Dr Reddy’s Laboratories to manufacture the diabetes and weight-management drug semaglutide in India for export to jurisdictions where Danish drugmaker Novo Nordisk does not have patent protection.
2 mins
March 10, 2026
Listen
Translate
Change font size
